Rhonda Pacheco

Rhonda Pacheco is President of Takeda’s U.S. Business Unit and U.S. Country Head, and a member of Takeda’s Executive Team. She leads a portfolio spanning gastroenterology, neuroscience, plasma-derived therapies and rare diseases, driving Takeda’s largest market in alignment with the company’s global strategy.

A PharmD and business leader with more than 20 years of experience across multiple countries and roles, Rhonda brings strategic acumen, operational excellence and people-first leadership. She joins Takeda from Eli Lilly, where she served as Group Vice President of U.S. Cardiometabolic Health. In that role, she built high-performing teams focused on improving patient outcomes, advancing health equity and expanding access to life-changing medicines. She also oversaw complex portfolios and product launches, including Lilly’s GLP-1 portfolio, delivering strong commercial results.

Rhonda is passionate about uniting diverse teams around a shared purpose. Her leadership aligns with Takeda’s values, purpose and vision, fostering teams that deliver meaningful impact for patients, partners and communities.

A Massachusetts native, Rhonda holds an MBA from Duke University’s Fuqua School of Business and a Doctor of Pharmacy from the University of Rhode Island.